Pseudoprogression and Rapid Response to Pembrolizumab in a Patient with Advanced Lung Adenocarcinoma with Loss of Epidermal Growth Factor Receptor Gene Mutation after Tyrosine Kinase Inhibitor Therapy

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Receptor Gene ◽

Growth Factor Receptor ◽

The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma

Lung Cancer ◽

10.1016/j.lungcan.2010.11.003 ◽

2011 ◽

Vol 73 (1) ◽

pp. 45-50 ◽

Cited By ~ 52

Author(s):

Yoshiki Kozu ◽

Koji Tsuta ◽

Takashi Kohno ◽

Ikuo Sekine ◽

Akihiko Yoshida ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Specific Antibodies ◽

Advanced Lung Adenocarcinoma Harboring a Mutation of the Epidermal Growth Factor Receptor: CT Findings after Tyrosine Kinase Inhibitor Therapy

Radiology ◽

10.1148/radiol.13121824 ◽

2014 ◽

Vol 270 (2) ◽

pp. 574-582 ◽

Cited By ~ 24

Author(s):

Chang-Min Choi ◽

Mi Young Kim ◽

Jae Cheol Lee ◽

Hwa Jung Kim

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03731-2 ◽

2021 ◽

Author(s):

Yu-Jin Wang ◽

Qing-Wen Wang ◽

Dong-Hu Yu ◽

Cong-Kuan Song ◽

Zi-Xin Guo ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Abstract 419: Presence of pulmonary tuberculosis impair survival in advancedEGFRmutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor

10.1158/1538-7445.am2021-419 ◽

2021 ◽

Author(s):

Yalin Xie ◽

Wei Zhou ◽

An Lei ◽

Zhan Huang ◽

Li Weiwei ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Pulmonary Tuberculosis ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

A leopard can’t change its spots: can a T790M mutation-positive cancer change its spots after epidermal growth factor receptor-tyrosine kinase inhibitor therapy?

Journal of Thoracic Disease ◽

10.21037/jtd.2018.10.53 ◽

2018 ◽

Vol 10 (S33) ◽

pp. S4113-S4113

Author(s):

Kai Obayashi ◽

Kimihiro Shimizu ◽

Seshiru Nakazawa ◽

Yoichi Ohtaki ◽

Natsuko Kawatani ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

T790m Mutation ◽

Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2016.79.4.248 ◽

2016 ◽

Vol 79 (4) ◽

pp. 248 ◽

Cited By ~ 20

Author(s):

Yoon Soo Chang ◽

Chang-Min Choi ◽

Jae Cheol Lee

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Resistance

Chemotherapy should be performed in epidermal growth factor receptor mutation-positive lung adenocarcinoma patients who had progressive disease to the first epidermal growth factor receptor-tyrosine kinase inhibitor

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000917 ◽

2020 ◽

Vol 31 (9) ◽

pp. 959-965

Author(s):

Kosuke Kashiwabara ◽

Shinji Fujii ◽

Shinsuke Tsumura ◽

Kazuhiko Sakamoto

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Progressive Disease ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-1654 ◽

2007 ◽

Vol 13 (3) ◽

pp. 799-805 ◽

Cited By ~ 41

Author(s):

Tetsuya Okano ◽

Tadashi Kondo ◽

Kiyonaga Fujii ◽

Toshihide Nishimura ◽

Toshimi Takano ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer WithEGFRMutations

Journal of Clinical Oncology ◽

10.1200/jco.2012.43.1858 ◽

2012 ◽

Vol 30 (27) ◽

pp. 3330-3336 ◽

Cited By ~ 33

Author(s):

Teresa Moran ◽

Lecia V. Sequist

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Feasibility of Surgical Resection After Induction Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Therapy for N2 Lung Adenocarcinomas

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2020.04.133 ◽

2021 ◽

Vol 111 (1) ◽

pp. 290-295

Author(s):

Weigang Zhao ◽

Tangbing Chen ◽

Chunyu Ji ◽

Liwen Xiong ◽

Rong Li ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Lung Adenocarcinomas